We are live on ! Find out more
ECP

Elk Creek Partners Portfolio holdings

AUM $582M
1-Year Est. Return 10.23%
This Fund
S&P 500
This Quarter Est. Return
-3.28%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$1.16B
AUM Growth
-$175M
Cap. Flow
-$71.1M
Cap. Flow %
-6.11%
Top 10 Hldgs %
23.85%
Holding
127
New
3
Increased
41
Reduced
72
Closed
11

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$16.6M
2
KPTI icon
Karyopharm Therapeutics
KPTI
+$11.5M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$10.8M
4
LGND icon
Ligand Pharmaceuticals
LGND
+$10.1M
5
MDRX
Veradigm Inc. Common Stock
MDRX
+$8.8M

Top Sells

Rank Stock Value
1
WAGE
WageWorks, Inc.
WAGE
+$21M
2
MDCO
Medicines Co
MDCO
+$13.7M
3
MTZ icon
MasTec
MTZ
+$13.5M
4
EFII
Electronics for Imaging
EFII
+$13.2M
5
IPHI
INPHI CORPORATION
IPHI
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 27.95%
2 Technology 17.01%
3 Industrials 12.32%
4 Consumer Discretionary 11.44%
5 Communication Services 11.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTT
126
DELISTED
GTT Communications, Inc.
GTT
– –
-309,923
Closed -$5.46M
EFII
127
DELISTED
Electronics for Imaging
EFII
– –
-357,190
Closed -$13.2M
2 3 4 5
6

Similar funds

BAC
Boys Arnold & Co Asheville, North Carolina $566M AUM 6.76% 1-Year Est. Return
AVC
Arlington Value Capital Salt Lake City, Utah $688M AUM 23.52% 1-Year Est. Return
OWD
Osborn Williams & Donohoe Cincinnati, Ohio $762M AUM 2.74% 1-Year Est. Return
PP
PagnatoKarp Partners Reston, Virginia $402M AUM 9.79% 1-Year Est. Return
WWM
Willingdon Wealth Management Huntersville, North Carolina $397M AUM 1.25% 1-Year Est. Return
JA
JOYN Advisors Atlanta, Georgia $300M AUM 14.91% 1-Year Est. Return
PL
PWMCO LLC Chicago, Illinois $299M AUM 14.98% 1-Year Est. Return
EA
Echinus Advisors New York $881M AUM 6.76% 1-Year Est. Return

Elk Creek Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Elk Creek Partners held 127 positions worth $1.16B, down 13% from $1.34B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Elk Creek Partners withdrew a net $71.1M in Q3 2019, closing 11 positions and reducing 72 holdings. Its most notable exit was WageWorks, Inc., an estimated $21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Elk Creek Partners opened a new position in Karyopharm Therapeutics worth $12.2M.

  • Elk Creek Partners's largest Q3 2019 buy was Karyopharm Therapeutics: 84,715 shares worth $12.2M.
  • Elk Creek Partners added most to Clovis Oncology, Inc. in Q3 2019, an estimated $16.6M increase.
  • Elk Creek Partners's biggest Q3 2019 reduction was MasTec, cutting an estimated $13.5M.
  • Elk Creek Partners fully exited WageWorks, Inc. in Q3 2019, selling an estimated $21M.
  • Elk Creek Partners's ten largest holdings make up 24% of its $1.16B portfolio in Q3 2019.
  • Elk Creek Partners opened 3 new positions and closed 11 in Q3 2019.
  • Elk Creek Partners's portfolio value fell 13% quarter-over-quarter to $1.16B.

Based on Elk Creek Partners's 13F filing for Q3 2019, filed 13 Nov 2019.